SPY342.73-0.65 -0.19%
DIA281.97-0.98 -0.35%
IXIC11,484.69-31.80 -0.28%

Pfizer And OPKO Announced The Phase 3 Results for Once-Weekly Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency Met Its Primary Endpoint Of Improved Treatment Burden

GENOTROPIN

· 10/08/2020 06:52

GENOTROPIN